Search Within

GME, Medicine

Formats
  1. Meeting Abstract (691)
  2. Journal Article (550)
  3. Review (142)
  4. Editorial (65)
  5. Research Letter (58)
  6. Correspondence (24)
  7. Miscellaneous (6)
  8. Book Section (5)
  9. Conference Paper (4)
  10. Guidelines (3)
Groups
  1. Graduate Medical Education (1548)
  2. Department of Medicine (1217)
  3. Hematology-Oncology Fellows (1017)
  4. Hematologic Malignancies, Division of (715)
  5. Solid Tumor Oncology Division (626)
  6. Weinberg Fellows (585)

More Groups

People
  1. Kylee Maclachlan (143)
  2. Gunjan Shah (137)
  3. Michael Scordo (133)
  4. Sergio Giralt (124)
  5. Saad Usmani (122)
  6. Alexander Lesokhin (111)

More People

Years
  1. 2025 (133)
  2. 2024 (369)
  3. 2023 (404)
  4. 2022 (323)
  5. 2021 (154)
  6. 2020 (73)

More Years

Publications
  1. Blood (254)
  2. Journal of Clinical Oncology (223)
  3. Clinical Lymphoma, Myeloma and Leukemia (46)
  4. Clinical Cancer Research (43)
  5. Annals of Oncology (37)
  6. Cancer Research (34)

More Publications

Publishers
  1. American Society of Hematology (290)
  2. American Society of Clinical Oncology (258)
  3. Elsevier Inc. (201)
  4. Nature Publishing Group (107)
  5. American Association for Cancer Research (101)
  6. Oxford University Press (69)

More Publishers

Results (1548)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The emerging role of antibody-drug conjugates in urothelial carcinoma
    Review

    Lattanzi, M.; Rosenberg, J. E.
    Expert Review of Anticancer Therapy (2020)

    Fulltext@MSK | Save
  • An intestinal organoid-based platform that recreates susceptibility to T-cell-mediated tissue injury
    Journal Article

    Matsuzawa-Ishimoto, Y.; Hine, A.; Shono, Y.; Rudensky, E.; Lazrak, A.; Yeung, F.; Neil, J. A.; Yao, X.; Chen, Y. H.; Heaney, T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • When is it OK to stop anti-programmed death 1 receptor (PD-1) therapy in metastatic melanoma?
    Review

    Banks, L. B.; Sullivan, R. J.
    American Journal of Clinical Dermatology (2020)

    Fulltext@MSK | Save
  • Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
    Research Letter

    Maura, F.; Rustad, E. H.; Yellapantula, V.; Łuksza, M.; Hoyos, D.; Maclachlan, K. H.; Diamond, B. T.; Greenbaum, B. D.; Morgan, G.; Lesokhin, A.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Co-occurrence of Merkel cell carcinoma and chronic inflammatory demyelinating polyneuropathy
    Correspondence

    Kuo, A. M. S.; Barker, C. A.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Immune-related adverse events of checkpoint inhibitors
    Review

    Ramos-Casals, M.; Brahmer, J. R.; Callahan, M. K.; Flores-Chávez, A.; Keegan, N.; Khamashta, M. A.; Lambotte, O.; Mariette, X.; Prat, A.; Suárez-Almazor, M. E.
    Nature Reviews Disease Primers (2020)

    Fulltext@MSK | Save
  • Antibiotic degradation by commensal microbes shields pathogens
    Journal Article

    Gjonbalaj, M.; Keith, J. W.; Do, M. H.; Hohl, T. M.; Pamer, E. G.; Becattini, S.
    Infection and Immunity (2020)

    Fulltext@MSK | Save
  • Maintenance therapy and need for cessation studies in multiple myeloma: Focus on the future
    Review

    Diamond, B.; Maclachlan, K.; Chung, D. J.; Lesokhin, A. M.; Landgren, C. O.
    Best Practice and Research: Clinical Haematology (2020)

    Fulltext@MSK | Save
  • Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action
    Review

    Wudhikarn, K.; Wills, B.; Lesokhin, A. M.
    Best Practice and Research: Clinical Haematology (2020)

    Fulltext@MSK | Save
  • Second malignancies in multiple myeloma; emerging patterns and future directions
    Review

    Maclachlan, K.; Diamond, B.; Maura, F.; Hillengass, J.; Turesson, I.; Landgren, C. O.; Kazandjian, D.
    Best Practice and Research: Clinical Haematology (2020)

    Fulltext@MSK | Save